AA
TCRR
AlphaCentric Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-151,000
| Closed | -$272K | – | 221 |
|
|
2022
Q3 | $272K | Buy |
+151,000
| New | +$272K | 0.28% | 81 |
|
|
2021
Q4 | $704K | Buy |
151,000
+38,000
| +34% | +$177K | 0.21% | 48 |
|
|
2021
Q3 | $962K | Buy |
113,000
+72,000
| +176% | +$613K | 0.24% | 33 |
|
|
2021
Q2 | $673K | Buy |
41,000
+35,500
| +645% | +$583K | 0.18% | 43 |
|
|
2021
Q1 | $121K | Buy |
5,500
+3,225
| +142% | +$71K | 0.04% | 128 |
|
|
2020
Q4 | $70K | Buy |
2,275
+375
| +20% | +$11.5K | 0.03% | 164 |
|
|
2020
Q3 | $39K | Buy |
+1,900
| New | +$39K | 0.02% | 122 |
|